Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Cabanillas

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Leukemia & Lymphoma|September 8, 2011
Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomasNina Shah, Fernando Cabanillas, Bradley McIntyre, et al.
Cancer Medicine|August 10, 2013
Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto RicoAna Patricia Ortiz, Orquidea Frías, Javier Pérez, et al.
Leukemia & Lymphoma|September 14, 2004
Establishment and characterization of a new mantle cell lymphoma cell line M-1Andre Goy, Yvonne K Remache, Jun Gu, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Radiotherapy alone for lymphocyte-predominant Hodgkin's diseasePamela J Schlembach, Richard B Wilder, Dan Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|October 8, 2003
Stage III follicular lymphoma: long-term follow-up and patterns of failureChul S Ha, Joseph S Kong, Peter McLaughlin, et al.
Cancer|March 17, 2004
Thalidomide for patients with recurrent lymphomaBarbara Pro, Anas Younes, Maher Albitar, et al.
Cancer|December 7, 2005
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemiaDeborah A Thomas, Andreas H Sarris, Jorge Cortes, et al.
Leukemia & Lymphoma|April 11, 2003
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomasHoon K Lee, Richard B Wilder, Dan Jones, et al.
Cancer|March 29, 2002
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin diseaseRichard B Wilder, Pamela J Schlembach, Dan Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphomaChul S Ha, Fernando Cabanillas, Ming S Lee, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|September 8, 2011
Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomasNina Shah, Fernando Cabanillas, Bradley McIntyre, et al.
Cancer Medicine|August 10, 2013
Breast cancer molecular subtypes and survival in a hospital-based sample in Puerto RicoAna Patricia Ortiz, Orquidea Frías, Javier Pérez, et al.
Leukemia & Lymphoma|September 14, 2004
Establishment and characterization of a new mantle cell lymphoma cell line M-1Andre Goy, Yvonne K Remache, Jun Gu, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Radiotherapy alone for lymphocyte-predominant Hodgkin's diseasePamela J Schlembach, Richard B Wilder, Dan Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|October 8, 2003
Stage III follicular lymphoma: long-term follow-up and patterns of failureChul S Ha, Joseph S Kong, Peter McLaughlin, et al.
Cancer|March 17, 2004
Thalidomide for patients with recurrent lymphomaBarbara Pro, Anas Younes, Maher Albitar, et al.
Cancer|December 7, 2005
Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemiaDeborah A Thomas, Andreas H Sarris, Jorge Cortes, et al.
Leukemia & Lymphoma|April 11, 2003
Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomasHoon K Lee, Richard B Wilder, Dan Jones, et al.
Cancer|March 29, 2002
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin diseaseRichard B Wilder, Pamela J Schlembach, Dan Jones, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2005
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphomaChul S Ha, Fernando Cabanillas, Ming S Lee, et al.
Pageof 11